Pharma Industry News

Mylan gets FDA nod for cost-saving HIV combo

The U.S. FDA approved Mylan’s Symfi, a triple combo once-daily HIV treatment for adult and pediatric patients who weigh at least 88 lbs.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]